1. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries 
Leo Ihlberg, MD, PhD, Henrik Nissen, MD, PhD, Niels-Erik Nielsen, MD, Andreas Rück, MD, Rolf Busund, MD, PhD, Kaj-Erik Klaarborg, MD, Lars Soendergaard, MD, PhD, Jan Harnek, MD, Heikki Miettinen, MD, PhD, Markku Eskola, MD, PhD, Alexander Wahba, MD, PhD, Mika Laine, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 146, Issue 5, Pages (November 2013)
DOI: /j.jtcvs
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
The mean and peak valve gradient 30 days after valve in valve transcatheter aortic valve implantation for different manufacturer-given internal diameters (IDs) was 18.3 ± 6.2 mm Hg, 16.4 ± 10.0 mm Hg, and 14.4 ± 7.5 mm Hg and ± 9.9 mm Hg, 30.3 ± 16.6 mm Hg, and 25.6 ± 12.3 mm Hg for an ID of less than 19 mm, 19 to 21 mm, and greater than 21 mm, respectively.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
The overall postoperative survival of the 45 valve in valve transcatheter aortic valve implantation patients.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions